Bone TransplantationBone BanksTransplantation, HomologousHematopoietic Stem Cell TransplantationGraft vs Host DiseaseTransplantation ConditioningBone and BonesBone Marrow TransplantationTransplantation, AutologousHematologic NeoplasmsLiver TransplantationGraft vs Leukemia EffectKidney TransplantationGraft vs Tumor EffectTreatment OutcomeLeukemiaRetrospective StudiesBone RemodelingStem Cell TransplantationHeart TransplantationGraft SurvivalRecurrenceLung TransplantationTime FactorsTissue DonorsTransplantation ChimeraBone DensityGraft RejectionAcute DiseaseBone MarrowSurvival RateTransplantation ImmunologyOrgan TransplantationBone Marrow CellsFollow-Up StudiesTransplantation, IsogeneicIslets of Langerhans TransplantationBone ResorptionImmunosuppressive AgentsTransplantationPancreas TransplantationRisk FactorsCell TransplantationHistocompatibility TestingWhole-Body IrradiationProspective StudiesBone NeoplasmsHistocompatibilityPeripheral Blood Stem Cell TransplantationCord Blood Stem Cell TransplantationImmunosuppressionBone DevelopmentSkin TransplantationTransplantation ToleranceBone DiseasesLiving DonorsTransplantation, HeterotopicBusulfanT-LymphocytesMice, Inbred C57BLIsoantigensSurvival AnalysisBone RegenerationHeart-Lung TransplantationMyeloablative AgonistsLymphocyte Culture Test, MixedRemission InductionCyclosporineTissue and Organ ProcurementBone MatrixHLA AntigensAnemia, AplasticLeukemia, Myeloid, AcutePostoperative ComplicationsFetal Tissue TransplantationChimerismCytomegalovirus InfectionsLiver FailureLymphocyte DepletionCorneal TransplantationHematopoietic Stem CellsTransplantation, HeterologousCombined Modality TherapyAntilymphocyte SerumVidarabineMice, Inbred BALB CLeukemia, Myelogenous, Chronic, BCR-ABL PositivePrecursor Cell Lymphoblastic Leukemia-LymphomaGraft vs Host ReactionTacrolimusCyclophosphamideDonor SelectionHematologic DiseasesMyelodysplastic SyndromesMesenchymal Stem Cell TransplantationCell DifferentiationHepatic Veno-Occlusive DiseaseRadiation ChimeraMultiple MyelomaWaiting Lists